Director/PDMR Shareholding

RNS Number : 4506F
Enteq Upstream PLC
16 November 2020
 

Enteq Upstream plc

(the "Company")

 

Director Shareholding

 

 

The Company received notification on 16 November 2020 that Andrew Law, Commercial Director acquired 125,000 ordinary shares of 1p each in the Company ("Ordinary Shares") at a price of 13.0p per Ordinary Share on 16 November 2020.  Following this acquisition, Mr Law has an interest in 724,326 Ordinary Shares, representing approximately 1.1 per cent. of the Company's issued ordinary share capital.

 

 

 

 

For further information, please contact:

 

Enteq Upstream plc

+44 (0)1494 618739

Martin Perry, Chief Executive Officer


David Steel, Finance Director

 

 


Investec Bank plc (NOMAD and Broker)

+44 (0)207 597 4000

Chris Treneman, Patrick Robb, David Anderson




 



 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Andrew Law

 

Reason for the notification

a)

Position/status

Commercial Director

b)

Initial notification/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Enteq Upstream

b)

LEI

2138006BKS2MOAPRUB75

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 1 pence each

 

GB00B41Q8Q68

b)

Nature of the transaction

Purchase

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

£0.1300

125,000

d)

Aggregated information

Not applicable - single transaction

e)

Date of the transaction

16 November 2020

f)

Place of the transaction

Outside a trading venue

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFLFIFLLLRLII
UK 100

Latest directors dealings